Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes

Current Cardiology Reports
Mohamed TelebZinnia T San Juan

Abstract

Diabetes mellitus is a chronic systemic disease with multiple complications ranging from microvascular to macrovascular diseases. Type 1 diabetes comprises 5 % of adults with diabetes in the US. This population is shown to be at increased risk of cardiovascular events and mortality. Intensive glycemic control has been consistently associated with decreased microvascular complications but trials on macrovascular benefit yielded mixed results over the years. Recent data from long-term observational follow-up studies of major diabetes cardiovascular events and mortality are showing benefits that were not seen with the initial interventional trials. This article will review evidence on the effect of glycemic control on complications in diabetes mellitus with a focus on cardiovascular mortality in type 1 diabetes.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 14, 1999·British Journal of Clinical Pharmacology·P KingR Donnelly
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Jul 12, 2007·The American Journal of Cardiology·Hertzel C GersteinUNKNOWN ACCORD Study Group
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·Robert G Dluhy, Graham T McMahon
Aug 2, 2008·Diabetes, Obesity & Metabolism·C AbrairaUNKNOWN VADT Group
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Oct 30, 2013·Cardiovascular Diabetology·Oliver SchnellAntonio Ceriello
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Danielle A J M SchoenakerUNKNOWN EURODIAB Prospective Complications Study Group
Nov 20, 2014·The New England Journal of Medicine·Marcus LindAnnika Rosengren
Nov 22, 2014·Diabetes Care·Richard F HammanUNKNOWN SEARCH for Diabetes in Youth Study Group
Jan 7, 2015·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the DCCT/EDIC Research GroupJohn M Lachin
Jun 4, 2015·The New England Journal of Medicine·Rodney A HaywardUNKNOWN VADT Investigators
Aug 1, 2015·Journal of the American College of Cardiology·Thomas NyströmUlrik Sartipy

❮ Previous
Next ❯

Citations

Jul 16, 2017·Heart·Viktorija Matuleviciene-AnängenMarcus Lind
Aug 17, 2018·Hormones : International Journal of Endocrinology and Metabolism·Zadalla MouslechApostolos I Hatzitolios

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.